News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
Investors included Bruker, whose MALDI mass spectrometry imaging platforms could have synergies with Ionpath's Multiplexed Ion Beam Imaging technology.
Planned and ongoing studies will use standardized plasma protein profiling workflows to discover biomarkers for a range of conditions.
Instead of measuring metabolites directly, the researchers used mass cytometry and multiplexed ion beam imaging to measure proteins involved in metabolic regulation.
Working with ETH Zurich researchers, the firm has incorporated machine learning to improve the platform's performance in complex organisms like humans.
The method uses DIA mass spec runs to adjust for drifts in LC retention times, allowing researchers to schedule more highly multiplexed experiments.
